✦ LIBER ✦

Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation?

✍ Scribed by Herwig Pokorny; Michael Gnant; Susanne Rasoul-Rockenschaub; Bernd Gollackner; Birgit Steiner; Günter Steger; Rudolf Steininger; Ferdinand Mühlbacher

Book ID: 114803394
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 243 KB
Volume: 5
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2005.00780.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors predicting response and survival

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

✍ Zafer Akçali; Ebru Akin; Özgür Özyilkan 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Factors predicting response and survival

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

✍ Thomas W. T. Leung; Amanda M. Y. Tang; Benny Zee; Simon C. H. Yu; Paul B. S. Lai 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Changes of host immunity in relation to

Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy

✍ Kouichi Momiyama; Hidenari Nagai; Yasukiyo Sumino 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 404 KB

221 IS EXPANDING MILAN CRITERIA SAFE? US

221 IS EXPANDING MILAN CRITERIA SAFE? USE OF EXPANDED CRITERIA FOR LIVER TRANSPLANT DOES NOT SIGNIFICANTLY DECREASE OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

✍ Q. Lai; A. Avolio; G. Tisone; A. Molinaro; F. Melandro; S. Agnes; P.B. Berloco; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB